Industry comparison

Manufacture of pharmaceuticals by regions.

Compare the eligible Manufacture of pharmaceuticals cohort across regions. Each row keeps company scale alongside health, profitability, growth and risk context.

SIC 2150-company minimum cohort Calculated 2 Jul 2026
Compare size bandsIndustry profile
Comparable regions9Eligible public cohorts
Company base1,809Across displayed regions
Largest cohort622London
Largest cohort health65Largest cohort’s average score
Eligible rows92 excluded below cohort
Invalid metric rows0Omitted instead of inferred

Cohort comparison

Manufacture of pharmaceuticals by regions

Ranked by company count. Profitability is a derived 0–100 score; lower insolvency-risk score is safer.

9 rows
#UK regionCompaniesHealth scoreProfitability scoreGross marginGrowthRisk
1 LondonE12000007 · find companies 622 65 40 187.6% 0.0% 28
2 South EastE12000008 · find companies 285 67 41 41.4% 0.0% 26
3 North WestE12000002 · find companies 208 65 41 29.4% 8.3% 27
4 East of EnglandE12000006 · find companies 200 69 42 39.7% 0.0% 26
5 West MidlandsE12000005 · find companies 118 66 40 47.8% 0.0% 29
6 Yorkshire and The HumberE12000003 · find companies 114 65 42 28.5% 0.0% 28
7 South WestE12000009 · find companies 95 68 41 52.8% 0.0% 26
8 East MidlandsE12000004 · find companies 85 66 41 30.8% 0.0% 28
9 WalesW99999999 · find companies 82 66 40 0.0% 0.0% 29
Benchmark context Companies House aggregate snapshot Minimum cohort 50 Calculated 2 Jul 2026